Prevention of OM-85 on Bronchiectasis Exacerbation
To Investigate the PRevention of OM-85 on Bronchiectasis Exacerbation (iPROBE): a Multicenter, Randomised, Double-dummy, Placebo-controlled Clinical Trial in Chinese Patients
Sponsor: Capital Medical University
A PHASE4 clinical study on Bronchiectasis With Acute Exacerbation, this trial is completed. The trial is conducted by Capital Medical University and has accumulated 12 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Oct 2023 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
▶ Show 7 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Completed PHASE4
-
Jan 2021 — Nov 2022 [monthly]
Completed PHASE4
-
May 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — May 2020 [monthly]
Completed PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed · Phase: PHASE3 → PHASE4
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Capital Medical University
- China Medical University, China
- Chinese Academy of Medical Sciences
- Peking University
- Tianjin Medical University
- Tongji University
- Wenzhou Medical University
- Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .